What is mPharma?
Founded in 2013 and headquartered in Ghana, mPharma operates a network of community pharmacies that function as mini-hospitals. These facilities offer a comprehensive suite of services, including medical consultations, diagnostics, and telehealth, alongside increased access to affordable medication. The company's innovative model addresses critical gaps in healthcare infrastructure and accessibility for millions across Africa, positioning it as a key player in the region's evolving health tech landscape.
How much funding has mPharma raised?
mPharma has raised a total of $68.3M across 5 funding rounds:
Series A
$6.6M
Series B
$9.7M
Series C
$17M
Debt
$5M
Series D
$30M
Series A (2017): $6.6M with participation from 4DX Ventures, Golden Palm Investments, and Social Capital
Series B (2019): $9.7M led by Unbound, Novastar Ventures, and Cem Garih
Series C (2020): $17M supported by CDC Group Plc
Debt (2022): $5M featuring Citi
Series D (2022): $30M backed by Unbound, Lux Capital, and JAM Fund
Key Investors in mPharma
4DX Ventures
4DX Ventures is an early-stage venture capital firm based in Ghana, Africa, with a focus on supporting companies poised for growth on the continent.
Golden Palm Investments
Golden Palm Investments Corporation is an investment holding company focused on high-growth technology opportunities in Africa, aiming to build world-class businesses.
Social Capital
Social Capital is an organization dedicated to advancing humanity by solving hard problems, investing in entrepreneurs who aim to improve lives globally.
What's next for mPharma?
The substantial enterprise-level funding, particularly the recent strategic investment, signals mPharma's advanced stage of growth and its strategic importance in the African healthcare sector. This capital is likely to fuel further expansion of its pharmacy network, enhance its technological capabilities for service delivery, and potentially support new service offerings. The company's trajectory suggests a continued focus on scaling its operations to reach a broader population, solidifying its position as a leader in accessible and affordable healthcare solutions across Africa.
See full mPharma company page
